106 related articles for article (PubMed ID: 15154878)
1. Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients.
Hashiba H; Aizawa S; Tamura K; Shigematsu T; Kogo H
Ther Apher Dial; 2004 Jun; 8(3):241-7. PubMed ID: 15154878
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects.
Hashiba H; Aizawa S; Tamura K; Kogo H
Ther Apher Dial; 2006 Feb; 10(1):59-64. PubMed ID: 16556138
[TBL] [Abstract][Full Text] [Related]
3. Prevention of aortic calcification by etidronate in the renal failure rat model.
Tamura K; Suzuki Y; Matsushita M; Fujii H; Miyaura C; Aizawa S; Kogo H
Eur J Pharmacol; 2007 Mar; 558(1-3):159-66. PubMed ID: 17270170
[TBL] [Abstract][Full Text] [Related]
4. [Suppressive effects of bisphosphonates on the vascular calcification in ESRD patients].
Tamura K; Hashiba H; Kogo H; Aizawa S; Shigematsu T
Clin Calcium; 2002 Aug; 12(8):1129-35. PubMed ID: 15775409
[TBL] [Abstract][Full Text] [Related]
5. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density.
Asmus HG; Braun J; Krause R; Brunkhorst R; Holzer H; Schulz W; Neumayer HH; Raggi P; Bommer J
Nephrol Dial Transplant; 2005 Aug; 20(8):1653-61. PubMed ID: 15930018
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
[TBL] [Abstract][Full Text] [Related]
7. Effects of discontinuation as well as intervention of cyclic therapy with etidronate on bone remodeling after cementless total hip arthroplasty.
Yamaguchi K; Masuhara K; Yamasaki S; Fuji T; Seino Y
Bone; 2004 Jul; 35(1):217-23. PubMed ID: 15207760
[TBL] [Abstract][Full Text] [Related]
8. [A study of aortic calcification uremia].
Nakagawa K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):135-43. PubMed ID: 9134830
[TBL] [Abstract][Full Text] [Related]
9. Phytate inhibits bovine pericardium calcification in vitro.
Grases F; Sanchis P; Costa-Bauzá A; Bonnin O; Isern B; Perelló J; Prieto RM
Cardiovasc Pathol; 2008; 17(3):139-45. PubMed ID: 18402805
[TBL] [Abstract][Full Text] [Related]
10. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients.
Seyahi N; Altiparmak MR; Kahveci A; Yetik H; Kanberoglu K; Serdengecti K; Ataman R; Erek E
Am J Kidney Dis; 2005 Mar; 45(3):550-6. PubMed ID: 15754277
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Lanthanum acetate inhibits vascular calcification induced by vitamin D3 plus nicotine in rats.
Zhou YB; Jin SJ; Cai Y; Teng X; Chen L; Tang CS; Qi YF
Exp Biol Med (Maywood); 2009 Aug; 234(8):908-17. PubMed ID: 19546357
[TBL] [Abstract][Full Text] [Related]
13. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
14. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K
J Rheumatol; 2008 Mar; 35(3):407-13. PubMed ID: 18260178
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis.
Nitta K; Akiba T; Suzuki K; Uchida K; Watanabe R; Majima K; Aoki T; Nihei H
Am J Kidney Dis; 2004 Oct; 44(4):680-8. PubMed ID: 15384019
[TBL] [Abstract][Full Text] [Related]
16. Short-term etidronate treatment prevents glucocorticoid-induced bone debility of the mandible in growing rats.
Fujita Y; Konoo T; Maki K
Orthod Craniofac Res; 2008 Nov; 11(4):187-95. PubMed ID: 18950314
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Itoh K; Tanaka M; Hashiguchi J; Funakoshi S; Nakano H; Kubo H; Kono T; Uchino J; Masaki K; Date T; Shigematsu T;
Ther Apher Dial; 2008 Apr; 12(2):126-32. PubMed ID: 18387160
[TBL] [Abstract][Full Text] [Related]
18. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
Bellasi A; Kooienga L; Block GA; Veledar E; Spiegel DM; Raggi P
J Nephrol; 2009; 22(2):255-62. PubMed ID: 19384844
[TBL] [Abstract][Full Text] [Related]
19. [Effect of oral biphosphonates in patients with cystic fibrosis and low bone mineral density].
Ringuier B; Leboucher B; Leblanc M; Troussier F; Duveau E; Audran M; Giniès JL
Arch Pediatr; 2004 Dec; 11(12):1445-9. PubMed ID: 15596332
[TBL] [Abstract][Full Text] [Related]
20. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
